| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tonsillectomy | 9 | 2020 | 69 | 3.840 |
Why?
|
| Sleep Apnea, Obstructive | 10 | 2020 | 142 | 2.910 |
Why?
|
| Laryngostenosis | 8 | 2018 | 13 | 2.870 |
Why?
|
| Down Syndrome | 6 | 2018 | 120 | 2.800 |
Why?
|
| Adenoidectomy | 10 | 2020 | 51 | 2.700 |
Why?
|
| Laryngomalacia | 6 | 2016 | 12 | 2.640 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 10 | 2020 | 62 | 2.550 |
Why?
|
| Velopharyngeal Insufficiency | 4 | 2019 | 14 | 2.210 |
Why?
|
| Larynx | 7 | 2020 | 49 | 2.100 |
Why?
|
| Child | 50 | 2023 | 6405 | 2.030 |
Why?
|
| Cochlear Implants | 3 | 2023 | 110 | 1.780 |
Why?
|
| Child, Preschool | 27 | 2020 | 3187 | 1.690 |
Why?
|
| Congenital Abnormalities | 4 | 2020 | 42 | 1.550 |
Why?
|
| Glottis | 6 | 2016 | 17 | 1.540 |
Why?
|
| Infant | 25 | 2022 | 2891 | 1.500 |
Why?
|
| Laryngoplasty | 4 | 2020 | 8 | 1.500 |
Why?
|
| Postoperative Complications | 11 | 2020 | 1615 | 1.430 |
Why?
|
| Deafness | 2 | 2022 | 64 | 1.230 |
Why?
|
| Cochlear Implantation | 2 | 2023 | 99 | 1.230 |
Why?
|
| Retrospective Studies | 31 | 2022 | 7277 | 1.160 |
Why?
|
| Airway Obstruction | 4 | 2016 | 49 | 1.120 |
Why?
|
| Endoscopy | 6 | 2020 | 464 | 1.100 |
Why?
|
| Tracheal Stenosis | 4 | 2022 | 21 | 1.090 |
Why?
|
| Trachea | 6 | 2022 | 48 | 1.090 |
Why?
|
| Deglutition Disorders | 4 | 2020 | 297 | 1.070 |
Why?
|
| Health Care Costs | 2 | 2020 | 346 | 1.030 |
Why?
|
| Humans | 77 | 2023 | 68618 | 1.010 |
Why?
|
| Hearing Loss | 3 | 2022 | 154 | 1.000 |
Why?
|
| Velopharyngeal Sphincter | 2 | 2015 | 7 | 0.990 |
Why?
|
| Quality Improvement | 5 | 2023 | 413 | 0.980 |
Why?
|
| Hearing Loss, Sensorineural | 2 | 2018 | 110 | 0.950 |
Why?
|
| Treatment Outcome | 22 | 2022 | 7029 | 0.940 |
Why?
|
| Weight Gain | 2 | 2017 | 135 | 0.890 |
Why?
|
| Length of Stay | 4 | 2020 | 780 | 0.860 |
Why?
|
| Male | 44 | 2020 | 37321 | 0.840 |
Why?
|
| Pneumococcal Infections | 1 | 2023 | 30 | 0.840 |
Why?
|
| Laryngoscopy | 6 | 2018 | 61 | 0.830 |
Why?
|
| Sleep Apnea Syndromes | 4 | 2020 | 40 | 0.810 |
Why?
|
| Congenital Hypothyroidism | 1 | 2022 | 6 | 0.810 |
Why?
|
| DiGeorge Syndrome | 3 | 2017 | 13 | 0.810 |
Why?
|
| Infant, Newborn | 10 | 2020 | 2455 | 0.800 |
Why?
|
| Female | 43 | 2020 | 38074 | 0.800 |
Why?
|
| Otolaryngology | 4 | 2023 | 38 | 0.770 |
Why?
|
| Postoperative Care | 2 | 2013 | 163 | 0.740 |
Why?
|
| Choanal Atresia | 2 | 2019 | 5 | 0.740 |
Why?
|
| Craniofacial Abnormalities | 3 | 2020 | 18 | 0.720 |
Why?
|
| Chromosome Disorders | 1 | 2020 | 31 | 0.690 |
Why?
|
| Surgical Flaps | 2 | 2019 | 120 | 0.690 |
Why?
|
| Adenoids | 3 | 2014 | 15 | 0.680 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2020 | 45 | 0.680 |
Why?
|
| Drug Prescriptions | 2 | 2020 | 135 | 0.670 |
Why?
|
| Pharynx | 2 | 2019 | 89 | 0.660 |
Why?
|
| Patient Readmission | 2 | 2019 | 267 | 0.660 |
Why?
|
| Pain, Postoperative | 2 | 2020 | 214 | 0.640 |
Why?
|
| Otorhinolaryngologic Diseases | 1 | 2018 | 14 | 0.630 |
Why?
|
| Rhinoplasty | 2 | 2020 | 27 | 0.620 |
Why?
|
| Analgesics, Opioid | 2 | 2020 | 498 | 0.600 |
Why?
|
| Mucociliary Clearance | 3 | 2012 | 21 | 0.580 |
Why?
|
| Health Resources | 1 | 2017 | 76 | 0.550 |
Why?
|
| Electronic Health Records | 1 | 2020 | 374 | 0.540 |
Why?
|
| Bronchoscopy | 6 | 2020 | 147 | 0.540 |
Why?
|
| Blood Transfusion | 1 | 2017 | 205 | 0.540 |
Why?
|
| Databases, Factual | 5 | 2020 | 622 | 0.520 |
Why?
|
| Durapatite | 1 | 2015 | 33 | 0.510 |
Why?
|
| Cleft Palate | 2 | 2013 | 34 | 0.510 |
Why?
|
| Cricoid Cartilage | 3 | 2018 | 10 | 0.510 |
Why?
|
| Hospitalization | 3 | 2020 | 978 | 0.510 |
Why?
|
| Prosthesis Failure | 1 | 2015 | 130 | 0.490 |
Why?
|
| Adolescent | 15 | 2020 | 8912 | 0.480 |
Why?
|
| Tracheostomy | 4 | 2020 | 31 | 0.470 |
Why?
|
| Anemia, Sickle Cell | 1 | 2017 | 364 | 0.450 |
Why?
|
| Methacholine Chloride | 2 | 2012 | 20 | 0.450 |
Why?
|
| Tracheotomy | 4 | 2019 | 17 | 0.450 |
Why?
|
| Patient Safety | 1 | 2015 | 202 | 0.450 |
Why?
|
| Isoproterenol | 2 | 2012 | 163 | 0.440 |
Why?
|
| Palate, Soft | 1 | 2013 | 12 | 0.440 |
Why?
|
| Nasal Obstruction | 1 | 2013 | 34 | 0.440 |
Why?
|
| Biocompatible Materials | 1 | 2015 | 247 | 0.440 |
Why?
|
| Follow-Up Studies | 10 | 2018 | 3259 | 0.430 |
Why?
|
| Palatine Tonsil | 1 | 2012 | 8 | 0.430 |
Why?
|
| Nasal Cavity | 1 | 2013 | 62 | 0.430 |
Why?
|
| Epiglottis | 1 | 2012 | 11 | 0.430 |
Why?
|
| Otitis Media with Effusion | 1 | 2012 | 9 | 0.430 |
Why?
|
| CHARGE Syndrome | 1 | 2012 | 2 | 0.430 |
Why?
|
| Vascular Neoplasms | 1 | 2012 | 15 | 0.430 |
Why?
|
| Vestibulocochlear Nerve Diseases | 1 | 2012 | 10 | 0.420 |
Why?
|
| Vascular Malformations | 1 | 2012 | 19 | 0.420 |
Why?
|
| Physical Stimulation | 1 | 2012 | 67 | 0.420 |
Why?
|
| Herpesvirus 4, Human | 1 | 2012 | 30 | 0.410 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2012 | 24 | 0.410 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2012 | 37 | 0.410 |
Why?
|
| Endosonography | 1 | 2013 | 177 | 0.400 |
Why?
|
| Growth and Development | 1 | 2011 | 4 | 0.390 |
Why?
|
| Pharyngeal Muscles | 1 | 2010 | 10 | 0.360 |
Why?
|
| Pneumonia, Aspiration | 2 | 2010 | 22 | 0.350 |
Why?
|
| Reoperation | 5 | 2020 | 467 | 0.340 |
Why?
|
| Surgeons | 2 | 2020 | 68 | 0.330 |
Why?
|
| Risk Assessment | 5 | 2018 | 2007 | 0.330 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2012 | 468 | 0.320 |
Why?
|
| Neck Injuries | 1 | 2008 | 17 | 0.310 |
Why?
|
| Case-Control Studies | 5 | 2013 | 1553 | 0.310 |
Why?
|
| Laryngeal Diseases | 1 | 2008 | 22 | 0.310 |
Why?
|
| Immunosuppressive Agents | 1 | 2012 | 514 | 0.310 |
Why?
|
| Risk Factors | 6 | 2020 | 5731 | 0.310 |
Why?
|
| Microsurgery | 1 | 2008 | 46 | 0.310 |
Why?
|
| Consensus | 4 | 2022 | 211 | 0.300 |
Why?
|
| Hypophysectomy | 2 | 2004 | 5 | 0.300 |
Why?
|
| United States | 6 | 2020 | 7367 | 0.300 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2008 | 131 | 0.290 |
Why?
|
| Severity of Illness Index | 5 | 2013 | 1851 | 0.280 |
Why?
|
| Cytosine | 1 | 2006 | 12 | 0.280 |
Why?
|
| Organophosphonates | 1 | 2006 | 16 | 0.270 |
Why?
|
| Postoperative Period | 2 | 2017 | 238 | 0.270 |
Why?
|
| Polysomnography | 2 | 2017 | 92 | 0.270 |
Why?
|
| Pediatrics | 3 | 2019 | 341 | 0.270 |
Why?
|
| Gastroesophageal Reflux | 2 | 2013 | 318 | 0.260 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2022 | 2324 | 0.260 |
Why?
|
| Esophagoscopy | 2 | 2020 | 72 | 0.260 |
Why?
|
| Cytomegalovirus Infections | 1 | 2006 | 69 | 0.260 |
Why?
|
| Intubation, Intratracheal | 3 | 2018 | 99 | 0.250 |
Why?
|
| Neuromuscular Agents | 2 | 2017 | 22 | 0.250 |
Why?
|
| Botulinum Toxins, Type A | 2 | 2017 | 31 | 0.250 |
Why?
|
| Clinical Competence | 2 | 2020 | 657 | 0.250 |
Why?
|
| Hypertrophy | 3 | 2014 | 89 | 0.250 |
Why?
|
| Abnormalities, Multiple | 1 | 2005 | 109 | 0.240 |
Why?
|
| Kidney Transplantation | 1 | 2012 | 839 | 0.240 |
Why?
|
| Burns | 1 | 2005 | 83 | 0.230 |
Why?
|
| Antiviral Agents | 1 | 2006 | 211 | 0.230 |
Why?
|
| Paranasal Sinuses | 2 | 2020 | 165 | 0.230 |
Why?
|
| Neuroendoscopy | 1 | 2003 | 4 | 0.230 |
Why?
|
| Adult | 12 | 2023 | 21403 | 0.220 |
Why?
|
| Lymphadenitis | 1 | 2023 | 5 | 0.220 |
Why?
|
| Vaccines, Conjugate | 1 | 2023 | 11 | 0.220 |
Why?
|
| Cerebrospinal Fluid Rhinorrhea | 1 | 2003 | 41 | 0.220 |
Why?
|
| Foreign Bodies | 2 | 2020 | 58 | 0.220 |
Why?
|
| Pneumococcal Vaccines | 1 | 2023 | 30 | 0.210 |
Why?
|
| Young Adult | 4 | 2017 | 5717 | 0.210 |
Why?
|
| Reference Values | 3 | 2013 | 579 | 0.210 |
Why?
|
| Mycobacterium Infections, Nontuberculous | 1 | 2023 | 37 | 0.210 |
Why?
|
| Cerebrovascular Trauma | 1 | 2022 | 7 | 0.210 |
Why?
|
| Carotid Artery Injuries | 1 | 2022 | 26 | 0.210 |
Why?
|
| Tobacco Smoke Pollution | 2 | 2014 | 127 | 0.200 |
Why?
|
| Eustachian Tube | 1 | 2002 | 31 | 0.200 |
Why?
|
| Otoacoustic Emissions, Spontaneous | 1 | 2022 | 19 | 0.200 |
Why?
|
| Time Factors | 3 | 2019 | 4655 | 0.200 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 1 | 2022 | 49 | 0.200 |
Why?
|
| Audiometry, Pure-Tone | 1 | 2022 | 96 | 0.200 |
Why?
|
| Vaccination | 1 | 2023 | 189 | 0.190 |
Why?
|
| Dermoid Cyst | 1 | 2020 | 4 | 0.190 |
Why?
|
| Auditory Threshold | 1 | 2022 | 206 | 0.190 |
Why?
|
| Bevacizumab | 1 | 2021 | 34 | 0.190 |
Why?
|
| Cochlea | 1 | 2022 | 169 | 0.190 |
Why?
|
| Achondroplasia | 1 | 2020 | 3 | 0.190 |
Why?
|
| Combined Modality Therapy | 4 | 2018 | 951 | 0.180 |
Why?
|
| Comorbidity | 3 | 2020 | 1426 | 0.180 |
Why?
|
| Nose Neoplasms | 1 | 2020 | 25 | 0.180 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2021 | 64 | 0.180 |
Why?
|
| Cohort Studies | 2 | 2017 | 2358 | 0.180 |
Why?
|
| Nasal Surgical Procedures | 1 | 2020 | 21 | 0.180 |
Why?
|
| Constriction, Pathologic | 3 | 2022 | 236 | 0.180 |
Why?
|
| Ear | 2 | 2013 | 12 | 0.180 |
Why?
|
| Respiratory System | 1 | 2020 | 28 | 0.180 |
Why?
|
| Delphi Technique | 4 | 2021 | 62 | 0.180 |
Why?
|
| Respiratory Tract Infections | 1 | 2021 | 91 | 0.170 |
Why?
|
| Racism | 1 | 2020 | 59 | 0.170 |
Why?
|
| Hemangioma | 2 | 2012 | 51 | 0.170 |
Why?
|
| Heart Defects, Congenital | 2 | 2020 | 596 | 0.170 |
Why?
|
| Insurance Coverage | 1 | 2020 | 99 | 0.170 |
Why?
|
| Hospitals, Pediatric | 3 | 2019 | 114 | 0.170 |
Why?
|
| Professional Role | 1 | 2019 | 80 | 0.170 |
Why?
|
| Physician Assistants | 1 | 2019 | 47 | 0.160 |
Why?
|
| Specialties, Surgical | 1 | 2019 | 19 | 0.160 |
Why?
|
| Nurse Practitioners | 1 | 2019 | 90 | 0.160 |
Why?
|
| Rhabdomyosarcoma, Embryonal | 1 | 2018 | 4 | 0.160 |
Why?
|
| Insurance, Health | 1 | 2020 | 201 | 0.160 |
Why?
|
| Pediatric Obesity | 1 | 2020 | 92 | 0.160 |
Why?
|
| Ear Neoplasms | 1 | 2018 | 13 | 0.160 |
Why?
|
| Ear, Middle | 1 | 2018 | 32 | 0.160 |
Why?
|
| Otitis Media | 2 | 2012 | 35 | 0.160 |
Why?
|
| Dilatation | 1 | 2018 | 58 | 0.150 |
Why?
|
| Papillomavirus Infections | 1 | 2021 | 194 | 0.150 |
Why?
|
| Palate | 1 | 2017 | 14 | 0.150 |
Why?
|
| Pyridostigmine Bromide | 1 | 2017 | 11 | 0.150 |
Why?
|
| Tongue | 1 | 2017 | 20 | 0.150 |
Why?
|
| Sucking Behavior | 1 | 2017 | 8 | 0.150 |
Why?
|
| Infant Behavior | 1 | 2017 | 12 | 0.150 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2017 | 58 | 0.150 |
Why?
|
| Sinusitis | 2 | 2014 | 432 | 0.150 |
Why?
|
| Hospital Charges | 1 | 2017 | 60 | 0.150 |
Why?
|
| Patient Discharge | 1 | 2020 | 294 | 0.150 |
Why?
|
| Bottle Feeding | 1 | 2017 | 20 | 0.150 |
Why?
|
| Postoperative Hemorrhage | 1 | 2017 | 69 | 0.140 |
Why?
|
| Respiration | 1 | 2017 | 91 | 0.140 |
Why?
|
| Mitomycin | 1 | 2016 | 27 | 0.140 |
Why?
|
| Hair | 2 | 2014 | 46 | 0.140 |
Why?
|
| Vocal Cord Paralysis | 1 | 2016 | 18 | 0.140 |
Why?
|
| Oximetry | 1 | 2016 | 29 | 0.140 |
Why?
|
| Feeding Behavior | 1 | 2017 | 224 | 0.130 |
Why?
|
| Infant, Premature | 1 | 2017 | 284 | 0.130 |
Why?
|
| Injections | 1 | 2015 | 119 | 0.130 |
Why?
|
| Recovery of Function | 1 | 2018 | 506 | 0.120 |
Why?
|
| Tissue Engineering | 1 | 2016 | 212 | 0.120 |
Why?
|
| Cross-Sectional Studies | 2 | 2020 | 2279 | 0.120 |
Why?
|
| Internship and Residency | 1 | 2020 | 596 | 0.120 |
Why?
|
| South Carolina | 3 | 2017 | 2752 | 0.120 |
Why?
|
| Schools, Medical | 1 | 2015 | 157 | 0.120 |
Why?
|
| Logistic Models | 3 | 2020 | 1420 | 0.120 |
Why?
|
| Incidence | 1 | 2018 | 1603 | 0.120 |
Why?
|
| Pyriform Sinus | 1 | 2013 | 2 | 0.110 |
Why?
|
| Chronic Disease | 3 | 2014 | 1330 | 0.110 |
Why?
|
| Nicotine | 2 | 2014 | 350 | 0.110 |
Why?
|
| Organ Size | 1 | 2014 | 242 | 0.110 |
Why?
|
| Body Mass Index | 1 | 2017 | 867 | 0.110 |
Why?
|
| Ribs | 1 | 2013 | 25 | 0.110 |
Why?
|
| Cartilage | 1 | 2013 | 51 | 0.110 |
Why?
|
| Respiratory Sounds | 1 | 2013 | 35 | 0.110 |
Why?
|
| Random Allocation | 2 | 2006 | 442 | 0.110 |
Why?
|
| Sialorrhea | 1 | 2012 | 7 | 0.110 |
Why?
|
| Airway Management | 1 | 2012 | 20 | 0.110 |
Why?
|
| Societies, Medical | 1 | 2015 | 403 | 0.110 |
Why?
|
| Brain | 1 | 2003 | 2176 | 0.110 |
Why?
|
| Cadaver | 1 | 2013 | 136 | 0.100 |
Why?
|
| Anesthetics, Intravenous | 1 | 2012 | 27 | 0.100 |
Why?
|
| Rhabdomyosarcoma | 2 | 2018 | 36 | 0.100 |
Why?
|
| Immune System Diseases | 1 | 2012 | 12 | 0.100 |
Why?
|
| Tertiary Care Centers | 1 | 2012 | 67 | 0.100 |
Why?
|
| Temporal Bone | 1 | 2012 | 53 | 0.100 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2012 | 33 | 0.100 |
Why?
|
| Immunocompromised Host | 1 | 2012 | 55 | 0.100 |
Why?
|
| Stents | 1 | 2016 | 657 | 0.100 |
Why?
|
| Parotitis | 1 | 2011 | 7 | 0.100 |
Why?
|
| Masseter Muscle | 1 | 2011 | 6 | 0.100 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2012 | 52 | 0.100 |
Why?
|
| Rituximab | 1 | 2012 | 61 | 0.100 |
Why?
|
| Cyclophosphamide | 1 | 2012 | 129 | 0.100 |
Why?
|
| Nephrectomy | 1 | 2012 | 103 | 0.100 |
Why?
|
| Nasal Mucosa | 1 | 2012 | 68 | 0.100 |
Why?
|
| Mycoses | 1 | 2012 | 60 | 0.100 |
Why?
|
| Muscular Diseases | 1 | 2011 | 41 | 0.100 |
Why?
|
| Craniosynostoses | 1 | 2011 | 9 | 0.100 |
Why?
|
| Tongue Diseases | 1 | 2011 | 14 | 0.100 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2012 | 181 | 0.100 |
Why?
|
| Gastrointestinal Diseases | 1 | 2012 | 107 | 0.100 |
Why?
|
| Body Height | 1 | 2011 | 67 | 0.100 |
Why?
|
| Edema | 1 | 2011 | 66 | 0.100 |
Why?
|
| Treatment Failure | 1 | 2011 | 216 | 0.090 |
Why?
|
| Prevalence | 3 | 2017 | 1619 | 0.090 |
Why?
|
| Cilia | 1 | 2012 | 94 | 0.090 |
Why?
|
| Failure to Thrive | 1 | 2010 | 17 | 0.090 |
Why?
|
| Prospective Studies | 3 | 2012 | 3705 | 0.090 |
Why?
|
| Age Factors | 1 | 2015 | 1864 | 0.090 |
Why?
|
| Lung Diseases | 1 | 2012 | 175 | 0.090 |
Why?
|
| Reproducibility of Results | 2 | 2013 | 2077 | 0.090 |
Why?
|
| Dendritic Cells | 1 | 2012 | 201 | 0.090 |
Why?
|
| Glucocorticoids | 1 | 2012 | 222 | 0.090 |
Why?
|
| Nasal Polyps | 1 | 2012 | 184 | 0.090 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 306 | 0.090 |
Why?
|
| Bacteria | 2 | 2008 | 193 | 0.080 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 1046 | 0.080 |
Why?
|
| Middle Aged | 6 | 2017 | 21147 | 0.080 |
Why?
|
| Recurrence | 1 | 2012 | 948 | 0.080 |
Why?
|
| Vitamin D Deficiency | 1 | 2012 | 292 | 0.080 |
Why?
|
| Gastrostomy | 1 | 2010 | 110 | 0.080 |
Why?
|
| Stroke | 1 | 2022 | 2163 | 0.080 |
Why?
|
| Body Weight | 1 | 2011 | 554 | 0.080 |
Why?
|
| Rhinitis | 1 | 2014 | 383 | 0.080 |
Why?
|
| Occipital Bone | 1 | 2009 | 11 | 0.080 |
Why?
|
| Clavicle | 1 | 2009 | 20 | 0.080 |
Why?
|
| Scapula | 1 | 2009 | 36 | 0.080 |
Why?
|
| Decision Making | 1 | 2012 | 410 | 0.080 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2008 | 117 | 0.080 |
Why?
|
| Rupture | 1 | 2008 | 29 | 0.080 |
Why?
|
| Laser Therapy | 1 | 2008 | 54 | 0.080 |
Why?
|
| Trauma Severity Indices | 1 | 2008 | 80 | 0.080 |
Why?
|
| Respiration, Artificial | 1 | 2009 | 190 | 0.080 |
Why?
|
| Syndrome | 2 | 2005 | 255 | 0.080 |
Why?
|
| Accidental Falls | 1 | 2008 | 84 | 0.070 |
Why?
|
| Disease Models, Animal | 2 | 2006 | 2550 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2012 | 2223 | 0.070 |
Why?
|
| Guinea Pigs | 1 | 2006 | 124 | 0.070 |
Why?
|
| Evoked Potentials, Auditory | 1 | 2006 | 47 | 0.070 |
Why?
|
| Urogenital Abnormalities | 1 | 2005 | 3 | 0.070 |
Why?
|
| Coloboma | 1 | 2005 | 2 | 0.070 |
Why?
|
| Laryngeal Neoplasms | 1 | 2006 | 47 | 0.060 |
Why?
|
| Growth Disorders | 1 | 2005 | 21 | 0.060 |
Why?
|
| Bronchiectasis | 1 | 2005 | 25 | 0.060 |
Why?
|
| Lacrimal Apparatus | 1 | 2005 | 9 | 0.060 |
Why?
|
| Eye Neoplasms | 1 | 2005 | 10 | 0.060 |
Why?
|
| Adenoma, Pleomorphic | 1 | 2005 | 10 | 0.060 |
Why?
|
| Cardiovascular Diseases | 1 | 2012 | 940 | 0.060 |
Why?
|
| Cystic Fibrosis | 1 | 2008 | 283 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 710 | 0.060 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2004 | 34 | 0.060 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2004 | 85 | 0.060 |
Why?
|
| Administration, Intranasal | 1 | 2004 | 88 | 0.060 |
Why?
|
| Equipment Contamination | 1 | 2004 | 38 | 0.060 |
Why?
|
| Atlanto-Axial Joint | 1 | 2003 | 13 | 0.060 |
Why?
|
| Debridement | 1 | 2003 | 55 | 0.060 |
Why?
|
| Joint Dislocations | 1 | 2003 | 40 | 0.050 |
Why?
|
| Nontuberculous Mycobacteria | 1 | 2023 | 22 | 0.050 |
Why?
|
| Lymph Node Excision | 1 | 2023 | 91 | 0.050 |
Why?
|
| Ear Diseases | 1 | 2002 | 37 | 0.050 |
Why?
|
| Surveys and Questionnaires | 2 | 2020 | 2800 | 0.050 |
Why?
|
| Pressure | 1 | 2002 | 252 | 0.050 |
Why?
|
| Angiography | 1 | 2022 | 194 | 0.050 |
Why?
|
| Esophagoscopes | 1 | 2020 | 5 | 0.050 |
Why?
|
| Internationality | 1 | 2021 | 74 | 0.050 |
Why?
|
| Head and Neck Neoplasms | 1 | 2006 | 561 | 0.040 |
Why?
|
| Elective Surgical Procedures | 1 | 2020 | 95 | 0.040 |
Why?
|
| Device Removal | 1 | 2020 | 100 | 0.040 |
Why?
|
| Patient-Centered Care | 1 | 2020 | 106 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2019 | 249 | 0.040 |
Why?
|
| Esophagus | 1 | 2020 | 303 | 0.040 |
Why?
|
| Faculty, Medical | 1 | 2019 | 110 | 0.040 |
Why?
|
| Income | 1 | 2019 | 167 | 0.040 |
Why?
|
| Neuroectodermal Tumors, Primitive, Peripheral | 1 | 2018 | 5 | 0.040 |
Why?
|
| Adenocarcinoma, Papillary | 1 | 2018 | 12 | 0.040 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 2018 | 12 | 0.040 |
Why?
|
| Prognosis | 2 | 2018 | 2093 | 0.040 |
Why?
|
| Chemoradiotherapy | 1 | 2018 | 54 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2020 | 446 | 0.040 |
Why?
|
| SEER Program | 1 | 2018 | 153 | 0.040 |
Why?
|
| Computed Tomography Angiography | 1 | 2022 | 424 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2020 | 880 | 0.040 |
Why?
|
| Disposable Equipment | 1 | 2017 | 12 | 0.040 |
Why?
|
| Medicaid | 1 | 2020 | 302 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2018 | 274 | 0.040 |
Why?
|
| Aged | 3 | 2014 | 14862 | 0.040 |
Why?
|
| Age Distribution | 1 | 2018 | 320 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2002 | 2083 | 0.040 |
Why?
|
| Animals | 2 | 2006 | 20881 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 536 | 0.040 |
Why?
|
| Disease Management | 1 | 2018 | 248 | 0.030 |
Why?
|
| Gestational Age | 1 | 2017 | 389 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2023 | 1026 | 0.030 |
Why?
|
| Equipment Design | 1 | 2017 | 500 | 0.030 |
Why?
|
| Survival Rate | 1 | 2018 | 1056 | 0.030 |
Why?
|
| Sleep Apnea, Central | 1 | 2015 | 6 | 0.030 |
Why?
|
| Hypoventilation | 1 | 2015 | 8 | 0.030 |
Why?
|
| Facial Bones | 1 | 2015 | 10 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2019 | 504 | 0.030 |
Why?
|
| Rats | 1 | 2002 | 5300 | 0.030 |
Why?
|
| Congenital Microtia | 1 | 2013 | 2 | 0.030 |
Why?
|
| Ear, External | 1 | 2013 | 14 | 0.030 |
Why?
|
| Otologic Surgical Procedures | 1 | 2013 | 23 | 0.030 |
Why?
|
| Thoracic Wall | 1 | 2013 | 20 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 772 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2014 | 381 | 0.030 |
Why?
|
| Transplantation, Autologous | 1 | 2013 | 145 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2017 | 1342 | 0.030 |
Why?
|
| Hospitals, University | 1 | 2013 | 169 | 0.030 |
Why?
|
| Placebos | 1 | 2012 | 195 | 0.030 |
Why?
|
| Cognition Disorders | 1 | 2015 | 342 | 0.020 |
Why?
|
| Cholecalciferol | 1 | 2012 | 143 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 507 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2012 | 765 | 0.020 |
Why?
|
| Acute Disease | 1 | 2011 | 658 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2011 | 186 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2012 | 1040 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 1174 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2012 | 1054 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2012 | 931 | 0.020 |
Why?
|
| Bacteriological Techniques | 1 | 2008 | 49 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2011 | 1140 | 0.020 |
Why?
|
| Obesity | 1 | 2015 | 1076 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2008 | 504 | 0.020 |
Why?
|
| Contraindications | 1 | 2006 | 52 | 0.020 |
Why?
|
| Survival | 1 | 2006 | 22 | 0.020 |
Why?
|
| Patient Care Planning | 1 | 2006 | 108 | 0.020 |
Why?
|
| Salvage Therapy | 1 | 2006 | 82 | 0.020 |
Why?
|
| 2-Propanol | 1 | 2004 | 4 | 0.010 |
Why?
|
| Sterilization | 1 | 2004 | 29 | 0.010 |
Why?
|
| Biopsy | 1 | 2006 | 540 | 0.010 |
Why?
|
| Immobilization | 1 | 2003 | 26 | 0.010 |
Why?
|
| Orthotic Devices | 1 | 2003 | 28 | 0.010 |
Why?
|
| Physical Therapy Modalities | 1 | 2003 | 133 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2006 | 848 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 2003 | 201 | 0.010 |
Why?
|